Current views on the etiopathogenesis of autoimmune thyroiditis (Hashimoto's disease);Współczesne pogla̧dy na temat etiopatogenezy autoimmunologicznego zapalenia tarczycy (choroby hashimoto)

Polski Merkuriusz Lekarski

Volumn 30, Issue 176, 2011, Pages 132-138

  Lacka, K ^a   Maciejewskl, A ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Autoimmune thyroiditis; Etiopathogenesis; Genetic factors

Indexed keywords

EPIDEMIOLOGY; FEMALE; GENETICS; HASHIMOTO DISEASE; HUMAN; IMMUNOLOGY; MALE; REVIEW; SEX RATIO;

CAUSALITY; FEMALE; HASHIMOTO DISEASE; HUMANS; MALE; SEX DISTRIBUTION;

EID: 79952918045     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Akeno N., Blackard J., Tomer Y.: HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. J. Autoimmun., 2008; 31(4): 339-44.
2. Aloisi F., Pujol-Borrell R.: Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol., 2006; 6(3): 205-17.
3. Ban Y., Greenberg D. A., Davies T. F. et al.: Linkage analysis of thyroid antibody production: evidence for shared susceptibility to clinical autoimmune thyroid disease. J. Clin. Endocrinol. Metab., 2008; 93(9): 3589-96.
4. Bartolomé J., Rodríguez-Inigo E., Quadros P. et al.: Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection. J. Med. Virol., 2008; 80(9): 1588-94.
5. Belguith-Maalej S., HadjKacem H., Rebai A. et al.: Thyroglobulln polymorphisms in Tunisian patients with autoimmune thyroid diseases (AITD). Immunobioiogy, 2008; 213(7): 577-83.
6. Bjoro T., Holmen J., Krüger O. et al.: Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur. J. Endocrinol., 2000; 143(5): 639-47.
7. Bossowski A., Czamocka B., Stasiak-Barmuta A. i wsp.: Analiza ekspresji czasteczek Fas, FasL oraz kaspazy 8 w tkance gruczotu tarczowego u młodych pacjentów z chorobami immunologicznymi I nieimmunologicznymi gruczohi tarczowego. Endokrynol. Pol., 2007; 58(4): 303-12.
8. Bottazzo G. F., Pujol-Borrell R., Hanafusa T. et al.: Role of aberrant HLADR expression and antigen presentation in induction of endocrine autoimmunity. Lancet, 1983; 2: 1115-9.
9. Caraccio N., Cuccato S., Pratesi F. et al.: Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures. Thyroid, 2009; 19(2): 149-55.
10. Chen R. H., Chang C. T., Chen W. C et al.: Proinflammatory cytokine gene polymorphisms among Hashimoto's thyroiditis patients. J. Clin. Lab. Anal., 2006; 20(6): 260-5.
11. Chistiakov D. A.: Immunogenetics of Hashimoto's thyroiditis. J. Autoimmune Dis., 2005; 2(1):1-21.
12. Czarnocka B., Ruf J., Ferrand M. et al.: Purification of the human thyroid peroxidase and its identification as the microsomal antigen Involved in autoimmune thyroid diseases. FEBS Lett, 1985; 190(1): 147-52.
13. Fernández-Mestre M., Sánchez K., Balbás O. et al.: Influence of CTLA-4 gene polymorphism in autoimmune and infectious diseases. Hum. Immunol., 2009; 70(7): 532-5.
14. Fountoulakis S., Vartholomatos G., Kolaitis N. et al.: Differential expression of Fas system apoptotic molecules in peripheral lymphocytes from patients with Graves' disease and Hashimoto's thyroiditis. Eur. J. Endocrinol., 2008; 158(6): 853-9.
15. Golden S. H., Robinson K. A., Saldanha I. et al.: Prevalence and incidence of endocrine and metabolic disorders In the United States: A Comprehensive Review. J. Clin. Endocrinol. Metab., 2009; I 94(6): 1853-78.
16. Graff-Baker A., Sosa J. A., Roman S. A.: Primary thyroid lymphoma: a review of recent developments in diagnosis and histology-driven treatment. Curr. Opin. Oncol., 2010; 22(1): 17-22.
17. Hashimoto H.: Zur Kenntniss der lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa). Arch. Klin. Chir, 1912; 97:219-48.
18. Hayashi F., Watanabe M., Nanba T. et al.: Association of the -31C/T functional polymorphism in the interleukin-lbeta gene with the Intractability of Graves' disease and the proportion of T helper type 17 cells. Clin. Exp. Immunol., 2009; 158(3): 281-6.
19. Inoue N., Watanabe M., Nanba T. et al.: Involvement of functional polymorphisms in the TNFA gene in the pathogenesis of autoimmune thyroid diseases and production of anti-thyrotropin receptor antibody. Clin. Exp. Immunol., 2009; 156(2): 199-204.
20. Ito C, Watanabe M., Okuda N. et al.: Association between the severity of Hashimoto's disease and the functional +874AJT polymorphism in the interieron-gamma gene. Endocr. J., 2006; 53(4): 473-8.
21. Jamil K. M., Leedman P. J., Kontorinis N. et al.: Interferon-induced thyroid dysfunction in chronic hepatitis C. J. Gastroenterol. Hepatol., 2009; 24(6): 1017-23.
22. Kawoura F. K., Akamizu T., Awata T. et al.: Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J. Clin. Endocrinol. Metab., 2007; 92(8): 3162-70.
23. Li H. S., Jiang H. Y., Carayanniotis G. et al.: Modifying effects of iodine on the immunogenicity ofthyroglobulin peptides. J. Autoimmun., 2007; 28(4): 171-6.
24. McLachlan S. M., Nagayama Y., Pichurin P.N. et al.: The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells. Endocrinology, 2007; 148(12): 5724-33.
25. Rekha P. L., Ishaq M., Valluri V: A differential association of interferongamma high-producing allele T and low-producing allele A (+874 AJT) with Hashimoto's thyroiditis and Graves' disease. Scand. J. Immunol., 2006; 64(4): 438-43.
26. Roitt I. M., Doniach D., Campbell P. N. et al.: Auto-antibodies in Hashimoto's disease (lymphadenoid goitre). Lancet, 1956; 271(6947): 820-1.
27. Takara M., Koukl T., DeGroot L. J.: CTLA-4 AT-repeat polymorphism reduces the inhibitory function of CTLA-4 in Graves'disease. Thyroid, 2003; 13(2): 1083-9.
28. Teng X., Shan Z., Teng W. et al.: Experimental study on the effects of chronic iodine excess on thyroid function, structure, and autoimmunity in autoimmune-prone NOD.H-2h4 mice. Clin. Exp. Med., 2009; 9(1): 51-9.
29. Xie L., Gao Y., Li M. et al.: Distribution of immunoglobulin G subclasses of anti-thyroid peroxidase antibody in sera from patients with Hashimoto's thyroiditis with different thyroid functional status. Clin. Exp. Immunol., 2008; 154(2): 172-76.
30. Yamada H., Watanabe M., Nanba T. et al.: The +869T/C polymorphism in the transforming growth factor-ß1 gene Is associated with the severity and intractability of autoimmune thyroid disease. Clin. Exp. Immunol., 2008; 151(3): 379-82.